FDA lays out stricter COVID vaccine policy in pivot from 'one-size-fits-all' approach

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for approvals in certain populations. | FDA Commissioner Marty Makary, M.D and CBER head Vinay Prasad, M.D., detailed their new approach to COVID vaccines in a Tuesday update. The agency leaders say they’re pursuing an “evidence-based approach to COVID-19 vaccination.”